Table 4.
Most Common Any‐Grade (≥5% of Patients) and All Grade ≥3 (≥1 Patient) Drug‐Related AEs
| Any‐Grade Drug‐Related AE, n (%) | Safety Population (N = 24) |
|---|---|
| Vomiting | 14 (58) |
| Nausea | 12 (50) |
| Fatigue | 6 (25) |
| Rasha | 5 (21) |
| Anemia | 4 (17) |
| Weight loss | 4 (17) |
| Decreased appetite | 3 (13) |
| Diarrhea | 3 (13) |
| Asthenia | 2 (8) |
| Chills | 2 (8) |
| Constipation | 2 (8) |
| Thrombocytopenia | 2 (8) |
| Grade ≥3 Drug‐Related AE, n (%) | |
| Anemia | 2 (8) |
| Dehydration | 1 (4) |
| Fatigue | 1 (4) |
| Peripheral edema | 1 (4) |
| Vomiting | 1 (4) |
Abbreviation: AE, adverse event.
a
Includes follicular rash, intermittent dark skin lesion, macular rash, maculopapular rash, pruritus.